PSMA targeted CAR-T therapy for prostate cancer

• Date : 2021-03-01
• 12    
  0

Pan-FGRF inhibitors in different FGFR alteration types across solid tumours

• Date : 2021-03-01
• 2    
  1

ZENITH20: Poziotinib efficacy and safety in NSCLC

• Date : 2021-03-01
• 1    
  0

Cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer

• Date : 2021-03-01
• 1    
  0

Efficacy and safety of MEDI1191 in patients with solid tumors and superficial lesions

• Date : 2021-03-01
• 0    
  0

STK11/ KEAP1 co-mutant lung adenocarcinoma is dependent on SCD1 to evade ferroptosis

• Date : 2021-03-01
• 0    
  0

Subtypes of EGFR- and HER2-mutant metastatic NSCLC influence response to ICIs

• Date : 2021-03-01
• 0    
  0

Safety of continued dosing of MEDI1191

• Date : 2021-03-01
• 0    
  0

Congrès ESMO 2026

• Date : 2026-10-23
• 16040    
  0

12ᵉ Congrès Mondial sur la Recherche et la Thérapie du Cancer

• Date : 2026-06-29
• 2053    
  0

Congrès de l’ESTRO 2026

• Date : 2026-05-15
• 1588    
  0

Congrès annuel de l’AACR 2026

• Date : 2026-04-17
• 1295    
  0

Congrès ESMO sur les sarcomes et les cancers rares 2026

• Date : 2026-03-12
• 1713    
  0